Research Article

Molecular Epidemiology of Carbapenem-Resistant Klebsiella pneumoniae in a Tertiary Hospital in Northern China

Table 2

The antimicrobial resistance profiles of 45 CRKP isolates.

AntibioticCRKP (n = 45)ST11 (n = 22)Others-ST (n = 23) valueICU (n = 22)Non-ICU (n = 23) value
Total resistance rate (%)Resistance rate (%)Resistance rate (%)Resistance rate (%)Resistance rate (%)

TZP77.8068.2087.000.00172.7082.600.088
AMC100.00100.00100.00100.00100.00
SCF100.00100.00100.00100.00100.00
CFZ100.00100.00100.00100.00100.00
CXM100.00100.00100.00100.00100.00
CRO100.00100.00100.00100.00100.00
FEP77.8072.7082.600.08872.7082.600.088
FOX71.1063.6078.300.02963.6078.300.029
IPM100.00100.00100.00100.00100.00
MEM100.00100.00100.00100.00100.00
ETP100.00100.00100.00100.00100.00
GEN40.0031.8047.800.02140.9039.100.773
AMK22.2031.8013.000.00127.3017.400.088
ATM93.30100.0087.00<0.001100.0087.00<0.001
TOB35.6031.8039.100.30140.9030.400.104
CIP91.10100.0082.60<0.001100.0082.60<0.001
LEV77.80100.0056.50<0.00190.9065.20<0.001
SXT60.0050.0069.600.00463.6056.500.273
TGC6.704.508.700.2684.508.700.268
COL11.109.1013.000.3664.5017.400.007

TZP, piperacillin/tazobactam; AMC, amoxicillin/clavulanic acid; SCF, cefoperazone-sulbactam; CFZ, cefazolin; CXM, cefuroxime; CRO, ceftriaxone; FEP, cefepime; FOX, cefoxitin; IPM, imipenem; MEM, meropenem; ETP, ertapenem; GEN, gentamicin; AMK, amikacin; ATM, aztreonam; TOB, tobramycin; CIP, ciprofloxacin; LEV, levofloxacin; SXT, trimethoprim/sulfamethoxazole; TGC, tigecycline; COL, colistin.